Russell Investments Group Ltd. lessened its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 24.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 451,218 shares of the technology company’s stock after selling 148,030 shares during the period. Russell Investments Group Ltd.’s holdings in Koninklijke Philips were worth $11,425,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Koninklijke Philips by 87.7% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company’s stock valued at $56,266,000 after buying an additional 1,038,321 shares in the last quarter. Brandes Investment Partners LP boosted its position in shares of Koninklijke Philips by 4.9% during the 4th quarter. Brandes Investment Partners LP now owns 918,635 shares of the technology company’s stock valued at $23,260,000 after acquiring an additional 43,157 shares during the last quarter. Natixis Advisors LLC grew its holdings in shares of Koninklijke Philips by 3.7% in the fourth quarter. Natixis Advisors LLC now owns 741,277 shares of the technology company’s stock valued at $18,769,000 after purchasing an additional 26,227 shares during the period. Raymond James Financial Inc. acquired a new stake in Koninklijke Philips during the fourth quarter worth about $10,655,000. Finally, Sei Investments Co. raised its stake in Koninklijke Philips by 5.2% during the fourth quarter. Sei Investments Co. now owns 308,673 shares of the technology company’s stock worth $7,816,000 after purchasing an additional 15,395 shares during the period. Hedge funds and other institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Stock Down 4.6 %
Koninklijke Philips stock opened at $22.67 on Friday. The company has a market capitalization of $21.30 billion, a PE ratio of -26.98, a price-to-earnings-growth ratio of 0.82 and a beta of 0.81. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23. Koninklijke Philips has a fifty-two week low of $19.25 and a fifty-two week high of $32.91. The firm has a 50 day moving average price of $25.93 and a 200 day moving average price of $27.02.
Koninklijke Philips Cuts Dividend
The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be given a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio is presently -89.29%.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on PHG shares. BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, March 8th. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. Finally, Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 18th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.
Read Our Latest Stock Report on Koninklijke Philips
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- Most active stocks: Dollar volume vs share volume
- Joby Aviation: Operational Momentum vs. Market Sentiment
- Using the MarketBeat Dividend Yield Calculator
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- Best Aerospace Stocks Investing
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.